Xianyong Ma

Xianyong Ma

EpigenoMax

2025

Technologies

Therapeutic

Indication

Basic Research

Clinical Research

Clinical Trials

Neurodegenerative Disease

Oncology

Executive Summary

View/Download

Additional Information

Immigrant-Led

Woman-Led

EpigenoMax Therapeutics is a startup biotech company focusing on the development of bioactive targeting drugs, “Precision Molecular Surgery Knife” for treatments of late-stage colorectal cancer 

Newsletter Signup

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Corporate Supporters

Program of

Initiated by